What is the dose of atropine (antimuscarinic agent) for bradycardia in children?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 25, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Atropine Dosing for Bradycardia in Children

For symptomatic bradycardia in children, the recommended dose of atropine is 0.02 mg/kg IV/IO, with a minimum single dose of 0.1 mg and maximum single dose of 0.5 mg for children and 1.0 mg for adolescents, which can be repeated every 5 minutes to a maximum total dose of 1 mg for children and 2 mg for adolescents. 1

Dosing Algorithm

Initial Dosing

  • For symptomatic vagally mediated bradycardia or AV block: 0.02 mg/kg IV/IO 1
  • Minimum single dose: 0.1 mg 1
  • Maximum single dose: 0.5 mg for a child, 1.0 mg for an adolescent 1
  • May be administered via endotracheal tube if IV/IO access is unavailable:
    • Neonates: 0.01-0.03 mg/kg 1
    • Children and adolescents: 0.03-0.06 mg/kg 1

Repeat Dosing

  • May repeat dose every 5 minutes as needed 1
  • Maximum total dose: 1 mg for a child, 2 mg for an adolescent 1

Clinical Considerations

First-Line Interventions

  • Oxygenation and ventilation are essential first maneuvers in treating symptomatic bradycardia 1
  • Epinephrine is the drug of choice if oxygen and adequate ventilation are not effective in treating hypoxia-induced bradycardia 1

Special Situations

  • For bradycardia associated with rapid sequence intubation (RSI): 0.01-0.02 mg/kg IV/IO (minimum dose: 0.1 mg; maximum dose: 1 mg) before administration of sedative/anesthetic and paralytic agents 1
  • For anticholinesterase poisoning: 0.05 mg/kg IV (up to initial adult dose of 2-5 mg), repeated as needed for clinical effect 1
    • For severe poisoning, doses may need to be doubled every 5 minutes 1

Important Considerations

Minimum Dose Considerations

  • Recent evidence suggests that the traditional minimum dose of 0.1 mg may not be necessary to prevent paradoxical bradycardia 1, 2
  • The 2015 American Heart Association guidelines state that a dose of 0.02 mg/kg with no minimum dose may be considered when atropine is used as premedication for emergency intubation 1

Efficacy and Safety

  • The dose-response relationship for atropine in children shows that 50% maximal response corresponds to 9 μg/kg, and 90% maximal response corresponds to 26 μg/kg 3
  • Contrary to previous beliefs, small doses of atropine (<0.1 mg) have not been shown to cause paradoxical bradycardia in young infants 2

Administration Considerations

  • Atropine sulfate comes in different concentrations; calculate dosage carefully 1
  • For IV/IO administration, administer by slow push for cardiac arrest 1
  • When administered via endotracheal tube, follow with or dilute in saline flush (1-5 mL) based on patient size 1

Potential Side Effects

  • May cause tachycardia, which could worsen ischemia in patients with acute coronary syndrome 4
  • Central nervous system effects may include hallucinations and fever with repeated administration 4

By following these dosing guidelines, clinicians can effectively manage bradycardia in pediatric patients while minimizing the risk of adverse effects.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Atropine Use in Bradycardia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.